“…Currently, deep hypothermic systemic circulatory arrest technology is available in clinical neurosurgery but has many disadvantages that mean the blood occlusion safe time cannot meet the clinical surgery operation time requirements; therefore, it can easily induce complications, such as blood viscosity, blood coagulation, arrhythmia, and respiratory failure (Cronberg et al, 2009). Previous study results have indicated that deep hypothermia with selective antegrade cerebral perfusion can improve cerebral endurance to ischemia and hypoxia in the cerebrum of rhesus monkeys, extend the safe time of blood occlusion, and avoid various systemic deep hypothermia complications (Yao, 2001;Elmistekawy and Rubens, 2011). In this study, the effectiveness and safety of selective cerebral deep hypothermic protection technology is further discussed by observing the change in hippocampal ultrastructure and vimentin expression in rhesus monkeys after recovery from selective deep hypothermia and blood occlusion.…”